Nanovibronix (FEED) & Its Competitors Critical Contrast

Nanovibronix (NASDAQ:FEED) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Nanovibronix to similar companies based on the strength of its profitability, dividends, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Nanovibronix and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	4252	10480	18203	824	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.60%. Given Nanovibronix’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its competitors.

Risk and Volatility

Nanovibronix has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, Nanovibronix’s competitors have a beta of 5.49, indicating that their average stock price is 449% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nanovibronix and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$1.93 million	-$18.18 million	-0.00
Nanovibronix Competitors	$1.87 billion	$138.21 million	10.75

Nanovibronix’s competitors have higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 12.2% of Nanovibronix shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Nanovibronix and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-1,093.61%	-60.73%	-48.48%
Nanovibronix Competitors	-278.23%	-150.07%	-21.87%

Summary

Nanovibronix competitors beat Nanovibronix on 12 of the 13 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.